Aspects radiologiques des métastases des cancers urologiques

25 novembre 2008

Auteurs : J.-M. Correas, A. Méjean, O. Hélénon
Référence : Prog Urol, 2008, 18, S196, suppl. S7


Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser






Albrecht T., Blomley M.J., Burns P.N., et al. Improved detection of hepatic metastases with pulse-inversion US during the liverspecific phase of SHU 508A: multicenter study Radiology 2003 ;  227 : 361-370 [cross-ref]
Quaia E., D’Onofrio M., Palumbo A., Rossi S., Bruni S., Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence Eur Radiol 2006 ;  16 : 1599-1609 [cross-ref]
Burns P.N., Wilson S.R. Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images Radiology 2007 ;  242 : 162-174 [cross-ref]
Castellino R.A. Retroperitoneal and pelvic lymph node imaging Cancer 1991 ;  67 : 1219-1222 [cross-ref]
Vinnicombe S.J., Norman A.R., Nicolson V., Husband J.E. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography Radiology 1995 ;  194 : 349-355Erratum in: Radiology 1995;196:800.  [cross-ref]
Thomsen H.S.European Society of Urogenital Radiology (ESUR) ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis Eur Radiol 2007 ;  17 : 2692-2696 [cross-ref]
Jager G.J., Barentsz J.O., Oosterhof G.O., Witjes J.A., Ruijs S.J. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetizationprepared-rapid gradient-echo sequence AJR Am J Roentgenol 1996 ;  167 : 1503-1507 [cross-ref]
Bellin M.F., Roy C., Kinkel K., et al. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience Radiology 1998 ;  207 : 799-808 [cross-ref]
Misselwitz B. MR contrast agents in lymph node imaging Eur J Radiol 2006 ;  58 : 375-382 [cross-ref]
Hövels A.M., Heesakkers R.A., Adang E.M., Jager G.J., Barentsz J.O. Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT Eur Radiol 2004 ;  14 : 1707-1712
Schmidt G.P., Schoenberg S.O., Schmid R., Stahl R., Tiling R., Becker C.R., Reiser M.F., Baur-Melnyk A. Screening for bone metastases: whole-body MRI using a 32-channel system versus dualmodality PET-CT Eur Radiol 2007 ;  17 : 939-949 [cross-ref]
Lauenstein T.C., Goehde S.C., Herborn C.U., Goyen M., Oberhoff C., Debatin J.F., Ruehm S.G., Barkhausen J. Whole-body MR imaging: evaluation of patients for metastases Radiology 2004 ;  233 : 139-148 [cross-ref]
Deserno W.M., Harisinghani M.G., Taupitz M., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging Radiology 2004 ;  233 : 449-456 [cross-ref]
Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 2003 ;  348 : 2491-2499Erratum in: N Engl J Med 2003;349:1010.  [cross-ref]
Nakanishi K., Kobayashi M., Nakaguchi K., Kyakuno M., Hashimoto N., Onishi H., Maeda N., Nakata S., Kuwabara M., Murakami T., Nakamura H. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images Magn Reson Med Sci 2007 ;  6 : 147-155 [cross-ref]
Schreyer H.H., Uggowitzer M.M. Ruppert-Kohlmayr. A helical CT of the urinary organs Eur Radiol 2002 ;  12 : 575-591 [cross-ref]
Yuh B.I., Cohan R.H., Francis I.R., Korobkin M. Ellis. Comparison of nephrographic with excretory phase helical computed tomography for detecting and characterizing renal masses Can Assoc Radiol J 2000 ;  51 : 170-176
Dekernion J.B., Ramming K., Smith R.B. The natural history of metastatic renal cell carcinoma: a computer analysis J Urol 1978 ;  120 : 148-152 [cross-ref]
Newhouse J.H., Amis E.S., Bigongiari L.R., et al. Follow-up of renal cell carcinoma. American College of Radiology ACR Appropriateness Criteria Radiology 2000 ;  215 : 761-764
Swanson D.A., Oravan W.L., Johnson D.E., Giacco G. Osseous metastasis secondary to renal cell carcinoma Urol 1981 ;  18 : 556-561 [cross-ref]
Hafez K.S., Novick A.C., Campbell S.C. Pattern of tumor recurrence and guidelines for follow-up after nephron sparing surgery for sporadic renal cell carcinoma J Urol 1997 ;  157 : 2067-2070 [cross-ref]
Yamanaka K., Gohji K., Hara I., Gotoh A., et al. Clinical Study of renal cell carcinoma with brain metastasis Int J Urol 1998 ;  5 : 124-128 [cross-ref]
Griffin N., Gore M.E., Sohaib S.A. Imaging in metastatic renal cell carcinoma AJR Am J Roentgenol 2007 ;  189 : 360-370 [cross-ref]
Schellinger P.D., Meinck H.M., Thron A. Diagnostic accuracy of MRI compared to CCT in patients with brain metastases J Neuro Oncol 1999 ;  44 (3) : 275-281 [cross-ref]
Recommandations du Comité de Cancérologie. Association Française d’Urologie (AFU), 2001.
Rouviere O., Brunereau L., Lyonnet D., Rouleau P. Bilan d’extension et surveillance des tumeurs malignes du rein J Radiol 2002 ;  83 : 805-824
Newhouse J.H., Amis E.S., Bigongiari L.R., et al. Follow-up of renal cell carcinoma. American College of Radiology ACR Appropriateness Criteria Radiology 2000 ;  215 : 761-764
Lee N., Newhouse J.H., Olsson C.A., Benson M.C., Petrylak D.P., Schiff P.B., Bagiella E., Malyszko B., Ennis R.D. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients Urology 1999 ;  54 : 490-494 [inter-ref]
World Health Organization Staff WHO handbook for reporting results of cancer treatment  Geneva: World Health Organization (1979). 
Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment Cancer 1981 ;  47 : 207-214 [cross-ref]
Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000 ;  92 : 205-216 [cross-ref]
Husband J.E., Schwartz L.H., Spencer J., Ollivier L., King D.M., Johnson R., Reznek R.International Cancer Imaging Society Evaluation of the response to treatment of solid tumours-a consensus statement of the International Cancer Imaging Society Br J Cancer 2004 ;  90 : 2256-2260
Therasse P., Eisenhauer E.A., Verweij J. RECIST revisited: a review of validation studies on tumour assessment Eur J Cancer 2006 ;  42 (8) : 1031-1039 [cross-ref]
Suzuki C., Jacobsson H., Hatschek T., Torkzad M.R., Bodén K., Eriksson-Alm Y., Berg E., Fujii H., Kubo A., Blomqvist L. Radiologic measurements of tumor response to treatment: practical approaches and limitations Radiographics 2008 ;  28 : 329-344 [cross-ref]
Julka P.K., Doval D.C., Gupta S., Rath G.K. Response assessment in solid tumours: a comparison of WHO. SWOG and RECIST guidelines Br J Radiol 2008 ;  81 (966) : 444-449 [cross-ref]
Benjamin R.S., Choi H., Macapinlac H.A., Burgess M.A., Patel S.R., Chen L.L., Podoloff D.A., Charnsangavej C. We should desist using RECIST, at least in GIST J Clin Oncol 2007 ;  25 : 1760-1764 [cross-ref]
Plathow C., Klopp M., Thieke C., Herth F., Thomas A., Schmaehl A., Zuna I., Kauczor H.U. Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT Eur Radiol 2008 ;  18 (8) : 1635-1643 [cross-ref]
Prasad S.R., Jhaveri K.S., Saini S., Hahn P.F., Halpern E.F., Sumner J.E. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations Radiology 2002 ;  225 : 416-419 [cross-ref]
Schwartz L.H., Mazumdar M., Wang L., Smith A., Marion S., Panicek D.M., Motzer R.J. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials Cancer 2003 ;  98 : 1611-1619 [cross-ref]
Lassau N., Chami L., Benatsou B., Peronneau P., Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment Eur Radiol 2007 ;  17 (6) : F89-98 [cross-ref]
Magnon C., Galaup A., Rouffiac V., Opolon P., Connault E., Rosé M., Perricaudet M., Roche A., Germain S., Griscelli F., Lassau N. Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration Gene Ther 2007 ;  14 : 108-117


© 2008  Elsevier Masson SAS. Tous droits réservés.